Europe has money, human resources and a basic-science base that produces world-leading cancer research. Why, then, aren’t these assets being translated into clinical advances?
Translating good science into new treatments
Hannah Brown
Related Articles
Cutting Edge
International biobanking regulations: the promise and the pitfalls
Senza categoria
A trial of strength
Senza categoria
Leave a Reply